Extrapyramidal side-effects (Q39277977)

10 September 2017

1 reference

title

Extrapyramidal side-effects (English)

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

4 November 2022

author name string

H. R. Bürki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A40265

4 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=40265

4 November 2022

publication date

1 January 1979

1 reference

full work available at URL

10 September 2017

https://api.elsevier.com/content/article/PII:016372587990127X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

https://api.elsevier.com/content/article/PII:016372587990127X?httpAccept=text/plain

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Pharmacology & Therapeutics

4 November 2022

published in

1 reference

10 September 2017

5

1 reference

10 September 2017

525-534

1 reference

10 September 2017

1-3

1 reference

Reciprocal effects on alpha- and gamma-motoneurones of drugs influencing monoaminergic and cholinergic transmission

10 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol

4 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

A survey of drug-induced extrapyramidal reactions

4 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Temperature responses and other effects of 5-hydroxytryptophan and 5-hydroxytryptamine when acting from the liquor space in unanaesthetized rabbits

4 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Clozapine and the Dopamine Hypothesis of Schizophrenia, a Critical Appraisal

4 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain

4 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Cholinergic- and neuroleptic-induced catalepsy: Modification by lesions in the caudate-putamen

4 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Catatonia induced in the rabbit by intracerebral injection of bradykinin and morphine

4 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol

4 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Dyskinesias elicited by methamphetamine: susceptibility of former methadone-consuming monkeys

4 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Behavioral evidence for dopaminergic supersensitivity following chronic treatment with methadone or chlorpromazine in the guinea pig

4 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

The effect of long-term ethanol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens

4 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Relation between the structure of certain methoxyphenylethylaminederivatives and the occurrence of a hypokinetic rigid syndrome

4 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptis

4 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Intrastriatal injection of quaternary butyrophenones and oxypertine: Neuroleptic effect in rats

4 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

An investigation on the central effects of harmine, harmaline and related beta-carbolines

4 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Dissociation between behavioral effects and changes in metabolism of cerebral serotonin following ?9-tetrahydrocannabinol

4 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

4 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol

4 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Alteration in the action of cholinergic and anti cholinergic drugs after chronic haloperidol: Indirect evidence for cholinergic hyposensitivity

4 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Preliminary Experiments on the Chemistry and Pharmacology of Cannabis

4 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

The effect of long-term penfluridol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens and in the corpus striatum

4 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Abnormal movements and rigidity induced by harmaline in relation to striatal acetylcholine, serotonin, and dopamine

4 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

An experimental model of tardive dyskinesia

4 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.

4 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia

4 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Morphine catalepsy in the rat: relation to striatal dopamine metabolism

4 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Narcotic dependence, narcotic action and dopamine receptors

4 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity

4 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Correlative neuroanatomical and neuropharmacological study of tremor and catatonia in the monkey

4 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Differential distribution of opiate and neuroleptic receptors and dopamine-sensitive adenylate cyclase in rat brain

4 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Measurement of acute and chronic behavioural effects of methamphetamine in the mouse

4 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Effect of metoclopramide on turnover of brain dopamine noradrenaline and 5-hydroxytryptamine

4 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

α-Flupenthixol-induced hyperactivity by chronic dosing in rats

4 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine

4 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects

4 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Animal Models for Tardive Dyskinesia: Effects of Thioridazine

4 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Adrenergic Effect of Chronic Administration of Neuroleptics

4 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment

4 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine

4 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

4 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Pharmacologically Induced Behavioural Supersensitivity to Apomorphine

4 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

4 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Behavioral effects of withdrawal of fluphenazine after long-term treatment

4 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Brain areas associated with bulbocapnine catalepsy

4 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment

4 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Predictability and specificity of behavioral screening tests for nucleoleptics

4 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Supersensitivity of caudate neurones after repeated administration of haloperidol

4 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Detection of dopaminergic supersensitivity induced by neuroleptic drugs in mice

4 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

Pharmacological differentiation of “nicotinic” and “muscarinic” catalepsy

4 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/0163-7258(79)90127-X

4 November 2022

Identifiers

1 reference

10 September 2017

1 reference